Literature DB >> 11798147

The role of the endothelium in hemolytic uremic syndrome.

C Zoja1, M Morigi, G Remuzzi.   

Abstract

Hemolytic uremic syndrome (HUS), which is the most common cause of acute renal failure in children, is caused by Shiga toxin-producing Escherichia coli infection. This infection leads to renal and other organ microvascular thrombosis. Endothelial injury has been recognized as the trigger event in the development of microangiopathic process. Evidence suggests that leukocyte as well as platelet activation participate in endothelial damage. Intrinsic abnormalities of the complement system may also play a role in HUS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11798147

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  6 in total

1.  Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: emerging insights for vascular integrity.

Authors:  Peter Densen
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

Review 2.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

3.  Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome.

Authors:  Tamara Manuelian; Jens Hellwage; Seppo Meri; Jessica Caprioli; Marina Noris; Stefan Heinen; Mihaly Jozsi; Hartmut P H Neumann; Giuseppe Remuzzi; Peter F Zipfel
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

4.  p38 mitogen-activated protein kinase mediates lipopolysaccharide and tumor necrosis factor alpha induction of shiga toxin 2 sensitivity in human umbilical vein endothelial cells.

Authors:  Matthew K Stone; Glynis L Kolling; Matthew H Lindner; Tom G Obrig
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

5.  Shiga toxin 1 induces on lipopolysaccharide-treated astrocytes the release of tumor necrosis factor-alpha that alter brain-like endothelium integrity.

Authors:  Verónica I Landoni; Pablo Schierloh; Marcelo de Campos Nebel; Gabriela C Fernández; Cecilia Calatayud; María J Lapponi; Martín A Isturiz
Journal:  PLoS Pathog       Date:  2012-03-29       Impact factor: 6.823

6.  Action of shiga toxin type-2 and subtilase cytotoxin on human microvascular endothelial cells.

Authors:  María M Amaral; Flavia Sacerdoti; Carolina Jancic; Horacio A Repetto; Adrienne W Paton; James C Paton; Cristina Ibarra
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.